Background/Aims: It has been suggested that eye makeup could interact with human meibum causing a decrease in the stability of the tear film. The aim of this pilot study was to measure makeup-human meibum interactions in vitro. Methods: Human meibum-makeup interactions were quantified by measuring order-to-disorder lipid phase transitions using infrared spectroscopy. Results: Makeup products exhibited lipid phase transition temperatures that were much higher than those for meibum. One product increased the lipid phase transition temperature by 4.2°C when combined with human meibum causing a large increase (from 30 to 49%) in the order of the meibum-lipid hydrocarbon chains and significantly decreased the minimum frequency, enthalpy and entropy of the phase transition of human meibum. Another eyeliner caused no significant (p < 0.05) change in the phase transition parameters of human meibum. Conclusion: Infrared spectroscopy may be used to measure interactions between human meibum and makeup. One makeup product increased the lipid order (viscosity) which could have adverse effects on tear film stability. Modern cosmetics are highly regulated and relatively safe to use; however, it could be beneficial to design makeup products that do not interact with meibum, especially since women have a higher prevalence of dry eye symptoms.

Keywords:
Dry eye, Infrared spectroscopy, Lipids, Makeup, Meibum
1.
Murube J: Ocular cosmetics in ancient times. Ocul Surf 2013;11:2–7.
2.
Murube J: Ocular cosmetics in modern times. Ocul Surf 2013;11:60–64.
3.
De Caluwé JP: Saturnine intoxication from the long-term use of kohl: an underestimated cause in French-speaking countries (in French). J Fr Ophtalmol 2009;32:459–463.
4.
Guillon JP: Abnormal lipid layers. Observation, differential diagnosis, and classification. Adv Exp Med Biol 1998;438:309–313.
5.
Tsubota K, Monden Y, Yagi Y, Goto E, Shimmura S: New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery. Br J Ophthalmol 1999;83:767–770.
6.
Goto E, Dogru M, Fukagawa K, Uchino M, Matsumoto Y, Saiki M, Tsubota K: Successful tear lipid layer treatment for refractory dry eye in office workers by low-dose lipid application on the full-length eyelid margin. Am J Ophthalmol 2006;142:264–270.
7.
Green-Church KB, Butovich I, Willcox M, Borchman D, Paulsen F, Barabino S, Glasgow BJ: The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci 2011;52:1979–1993.
8.
Schaumberg DA, Sullivan DA, Dana MR: Epidemiology of dry eye syndrome. Adv Exp Med Biol 2002;506:989–998.
9.
Pflugfelder SC: Prevalence, burden, and pharmacoeconomics of dry eye disease. Am J Manag Care 2008;14(suppl):S102–S106.
10.
Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK: The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 2011;52:1994–2005.
11.
Borchman D, Foulks GN, Yappert MC, Bell J, Wells E, Neravetla S, Greenstone V: Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci 2011;52:3805–3817.
12.
Borchman D, Foulks GN, Yappert MC, Tang D, Ho DV: Temperature-induced conformational changes in human tear lipids hydrocarbon chains. Biopolymers Biospectrosc 2007;87:124–133.
13.
Borchman D, Yappert MC, Milliner S, Duran D, Cox GW, Smith RJ, Bhola R: 13C and 1H NMR ester region resonance assignments and the composition of human infant and child meibum. Exp Eye Res 2013;112:151–159.
14.
Chew CKS, Hykin PG, Janswijer C, Dikstein S, Tiffany JM, Bron AJ: The casual level of meibomian lipids in humans. Curr Eye Res 1993;12:255–259.
15.
Borchman D: From the bench to the bedside. Infrared spectroscopy and the diagnosis and treatment of dry eye and cataracts. Spectroscopy 2014;29:38–52.
16.
Wei XE, Markoulli M, Millar TJ, Willcox MD, Zhao Z: Divalent cations in tears, and their influence on tear film stability in humans and rabbits. Invest Ophthalmol Vis Sci 2012;53:3280–3285.
17.
Nicolaides N, Santos EC: The di- and triesters of the lipids of steer and human meibomian glands. Lipids 1985;20:454–467.
18.
Rantamäki AH, Wiedmer SK, Holopainen JM: Melting points – the key to the anti-evaporative effect of the tear film wax esters. Invest Ophthalmol Vis Sci 2013;54:5211–5217.
19.
Ashraf Z, Pasha U, Greenstone V, Akbar J, Borchman D: Quantification of human sebum on skin and human meibum on the eyelid margin using Sebutape®, spectroscopy and chemical analysis. Curr Eye Res 2011;36:553–562.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.